Category: Pharmaceuticals
FDA Advisory Committee Recommends approval of new Alzheimer’s drug Donanemab
If approved, donanemab would be the third FDA approved disease-modifying beta-amyloid treatment for Alzheimer’s disease.
Generic Drugs: Are they different?
Standards in place for generic drugs should give consumers confidence that these products are just as effective as their brand-name equivalent.
Binders, fillers and more? What’s all that other stuff in my medicine?
Non-medicinal products in your medicine are there for a reason.
We finally learn from TACT2 what we should have known two decades ago: Chelation therapy doesn’t work for heart disease
At SBM, we've long argued that chelation therapy for heart disease is quackery. An abstract presented recently finally confirmed that. Why did it take so long?
SARMs Harms
Selective androgen receptor (SARMs) are sports supplements marketed to teens via social media influencers.
AI for prescription drug information: Not yet useful for health care – but it’s coming
ChatGPT may not replace a health care professional's assessment yet, but its capabilities are growing.
Adios Aduhelm
The controversial and never-proven-effective drug to treat Alzheimer's disease, aducanumab (Aduhelm) has been discontinued.
First CRISPR Treatment Approval
The first CRISPR-based therapy approval is a milestone worthy of noting.
Decongestant doesn’t work, concludes FDA advisory committee
An FDA advisory committee has concluded that phenylephrine, a popular decongestant in cough and cold remedies, is ineffective.
The (Cold) Drugs Don’t Work
The FDA continues to permit the inclusion of an ineffective ingredient in hundreds of cough and cold products.